---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-054459"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2026-08-06T21:07:12+00:00"
generated_at: "2026-08-06T21:08:27.134034+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Q2 revenue $9.7M (-3% YoY), net loss $0.7M; withdraws FY2026 guidance on CMS reimbursement uncertainty

## Summary
- Revenue $9.7M, down 3% from $10.1M in Q2 2025; gross margin 76.2% vs 78.1%.
- GAAP operating loss $(0.3)M vs income $1.4M; net loss $0.7M vs net income $0.6M.
- Adjusted EBITDA $1.2M, down from $3.2M; Ultramist system sales fell to 82 units from 116.
- Ultramist applicator revenue rose 13% to $7.3M, driven by 27% YoY unit volume growth.
- Withdraws FY2026 guidance due to CMS proposed 2027 97610 reimbursement rule; will reassess after final rule.

## SEC filing metadata
- accession: 0001628280-26-054459
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2026-08-06T21:07:12+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828026054459/0001628280-26-054459-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828026054459/snwv-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-054459
- JSON: https://secwatch.observer/filing/0001628280-26-054459.json
- Plain text: https://secwatch.observer/filing/0001628280-26-054459.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.